Skip to main content
Top
Published in: Diabetologia 6/2015

01-06-2015 | Commentary

Tuning to the right signal

Author: Mark O. Huising

Published in: Diabetologia | Issue 6/2015

Login to get access

Abstract

Pancreatic beta cells are clustered in islets of Langerhans together with alpha cells in an arrangement that facilitates the tight coordination of insulin and glucagon secretion at the source of their release. Other secretory cells, including somatostatin-secreting delta cells and pancreatic polypeptide cells, co-localise with alpha and beta cells in the islet and serve to modulate islet endocrine output. A multitude of non-secretory cell types, including endothelial cells, pericytes, stromal cells, glial cells and macrophages, complete the cellular make up of the islet, which is further enhanced by (para)sympathetic nerve terminals that impinge on the islets via neurotransmitters released in the islet microenvironment. While this islet architecture is relatively simple compared with the vast complexity of the central nervous system, the constellation of cell types united in the islet nevertheless provides a rich substrate for local paracrine and autocrine interactions that affect diverse aspects of islet physiology, ranging from the modulation of hormone secretion to the regulation of islet cell mass via proliferation and death. In this issue of Diabetologia (DOI: 10.​1007/​s00125-015-3552-5), Yang et al take the notion of rich crosstalk within the islet as their point of departure for a systematic evaluation of the beta cell-protective properties of an extensive panel of over 200 factors, with some surprising and highly interesting results, as discussed in this commentary.
Literature
1.
go back to reference Mezza T, Kulkarni RN (2014) The regulation of pre- and post-maturational plasticity of mammalian islet cell mass. Diabetologia 57:1291–1303CrossRefPubMed Mezza T, Kulkarni RN (2014) The regulation of pre- and post-maturational plasticity of mammalian islet cell mass. Diabetologia 57:1291–1303CrossRefPubMed
2.
go back to reference Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human beta-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205–2213CrossRefPubMedCentralPubMed Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF (2012) Human beta-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 61:2205–2213CrossRefPubMedCentralPubMed
3.
go back to reference Quan W, Jo EK, Lee MS (2013) Role of pancreatic beta-cell death and inflammation in diabetes. Diabetes Obes Metab 15(Suppl 3):141–151CrossRefPubMed Quan W, Jo EK, Lee MS (2013) Role of pancreatic beta-cell death and inflammation in diabetes. Diabetes Obes Metab 15(Suppl 3):141–151CrossRefPubMed
4.
go back to reference Yang YHC, Wills QF, Johnson JD (2015) A live-cell, high-content imaging survey of 206 biologic factors across 5 stress conditions reveals context-dependent survival effects in primary beta-cells. Diabetologia. doi:10.1007/s00125-015-3552-5 Yang YHC, Wills QF, Johnson JD (2015) A live-cell, high-content imaging survey of 206 biologic factors across 5 stress conditions reveals context-dependent survival effects in primary beta-cells. Diabetologia. doi:10.​1007/​s00125-015-3552-5
5.
go back to reference Yang YHC, Szabat M, Bragagnini C et al (2011) Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 54:828–842CrossRefPubMed Yang YHC, Szabat M, Bragagnini C et al (2011) Paracrine signalling loops in adult human and mouse pancreatic islets: netrins modulate beta cell apoptosis signalling via dependence receptors. Diabetologia 54:828–842CrossRefPubMed
6.
go back to reference Rodriguez-Diaz R, Dando R, Jacques-Silva MC et al (2011) Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med 17:888–892CrossRefPubMedCentralPubMed Rodriguez-Diaz R, Dando R, Jacques-Silva MC et al (2011) Alpha cells secrete acetylcholine as a non-neuronal paracrine signal priming beta cell function in humans. Nat Med 17:888–892CrossRefPubMedCentralPubMed
7.
go back to reference Kutlu B, Burdick D, Baxter D et al (2009) Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genet 2:3 Kutlu B, Burdick D, Baxter D et al (2009) Detailed transcriptome atlas of the pancreatic beta cell. BMC Med Genet 2:3
8.
9.
go back to reference Brissova M, Aamodt K, Brahmachary P et al (2014) Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration. Cell Metab 19:498–511CrossRefPubMedCentralPubMed Brissova M, Aamodt K, Brahmachary P et al (2014) Islet microenvironment, modulated by vascular endothelial growth factor-A signaling, promotes beta cell regeneration. Cell Metab 19:498–511CrossRefPubMedCentralPubMed
11.
go back to reference Hara M, Wang X, Kawamura T et al (2003) Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am J Physiol Endocrinol Metab 284:E177–E183CrossRefPubMed Hara M, Wang X, Kawamura T et al (2003) Transgenic mice with green fluorescent protein-labeled pancreatic beta-cells. Am J Physiol Endocrinol Metab 284:E177–E183CrossRefPubMed
12.
go back to reference Brouwers B, de Faudeur G, Osipovich AB et al (2014) Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. Cell Metab 20:979–990CrossRefPubMed Brouwers B, de Faudeur G, Osipovich AB et al (2014) Impaired islet function in commonly used transgenic mouse lines due to human growth hormone minigene expression. Cell Metab 20:979–990CrossRefPubMed
13.
go back to reference Benner C, van der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedCentralPubMed Benner C, van der Meulen T, Caceres E, Tigyi K, Donaldson CJ, Huising MO (2014) The transcriptional landscape of mouse beta cells compared to human beta cells reveals notable species differences in long non-coding RNA and protein-coding gene expression. BMC Genomics 15:620CrossRefPubMedCentralPubMed
14.
go back to reference Nica AC, Ongen H, Irminger JC et al (2013) Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res 23:1554–1562CrossRefPubMedCentralPubMed Nica AC, Ongen H, Irminger JC et al (2013) Cell-type, allelic, and genetic signatures in the human pancreatic beta cell transcriptome. Genome Res 23:1554–1562CrossRefPubMedCentralPubMed
15.
go back to reference Schuit FC, Derde MP, Pipeleers DG (1989) Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32:207–212CrossRefPubMed Schuit FC, Derde MP, Pipeleers DG (1989) Sensitivity of rat pancreatic A and B cells to somatostatin. Diabetologia 32:207–212CrossRefPubMed
16.
go back to reference Prothiwa M, Syed I, Huising MO et al (2014) Data-driven synthesis of proteolysis-resistant peptide hormones. J Am Chem Soc 136:17710–17713CrossRefPubMed Prothiwa M, Syed I, Huising MO et al (2014) Data-driven synthesis of proteolysis-resistant peptide hormones. J Am Chem Soc 136:17710–17713CrossRefPubMed
18.
go back to reference Omar BA, Liehua L, Yamada Y, Seino Y, Marchetti P, Ahrén B (2014) Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 57:1876–1883CrossRefPubMed Omar BA, Liehua L, Yamada Y, Seino Y, Marchetti P, Ahrén B (2014) Dipeptidyl peptidase 4 (DPP-4) is expressed in mouse and human islets and its activity is decreased in human islets from individuals with type 2 diabetes. Diabetologia 57:1876–1883CrossRefPubMed
20.
Metadata
Title
Tuning to the right signal
Author
Mark O. Huising
Publication date
01-06-2015
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 6/2015
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-015-3567-y

Other articles of this Issue 6/2015

Diabetologia 6/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine